This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Jun Anabuki: Innovator in Pharmaceutical Agents
Introduction
Jun Anabuki is a notable inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of concomitant pharmaceutical agents. Her work is recognized for its potential impact on medical treatments and patient care.
Latest Patents
Anabuki holds a patent for "Concomitant pharmaceutical agents and use thereof." This patent describes a concomitant agent that can be used simultaneously or separately, comprising a combination of specific chemical compounds. The primary compound detailed in her patent is 3-{(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine, along with its salts and solvates.
Career Highlights
Jun Anabuki is affiliated with Mitsubishi Tanabe Pharma Corporation, where she continues to advance her research and development efforts. Her work at the company has positioned her as a key player in the pharmaceutical industry, contributing to innovative solutions for complex medical challenges.
Collaborations
Anabuki collaborates with esteemed colleagues, including Yuji Abe and Fumihiko Akahoshi. These partnerships enhance her research capabilities and foster a collaborative environment for innovation.
Conclusion
Jun Anabuki's contributions to pharmaceutical innovations exemplify her dedication to improving healthcare through science. Her patent and ongoing work at Mitsubishi Tanabe Pharma Corporation highlight her role as a leading inventor in the industry.